XT
CTXR icon

XTX Topco’s Citius Pharmaceuticals CTXR Stock Holding History

XTX Topco’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2K Sell
21,295
-85,823
-80% -$69.3K ﹤0.01% 3558
2025
Q4 		$83.2K Buy
107,118
+91,196
+573% +$114K ﹤0.01% 2685
2025
Q3 		$19.7K Sell
15,922
-4,224
-21% -$5.89K ﹤0.01% 2334
2025
Q2 		$32K Buy
+20,146
New +$18.5K ﹤0.01% 2094
2024
Q4 		– Sell
-3,730
Closed -$46.7K – 2397
2024
Q3 		$46.7K Buy
+3,730
New +$62.8K ﹤0.01% 1702
2024
Q2 		– Sell
-3,104
Closed -$69.6K – 1975
2024
Q1 		$69.6K Buy
3,104
+2,596
+511% +$47.4K 0.01% 1416
2023
Q4 		$9.62K Sell
508
-655
-56% -$12.4K ﹤0.01% 1432
2023
Q3 		$19.9K Buy
+1,163
New +$27.6K ﹤0.01% 1375

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

XTX Topco's CTXR Position: Q1 2026 in Review

XTX Topco reduced its Citius Pharmaceuticals (CTXR) stake by 80% in Q1 2026, selling an estimated $69.3K and leaving 21,295 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3558.

XTX Topco first reported a position in CTXR in Q3 2023 and has held it in 8 quarters since. The position peaked at $83.2K in Q4 2025. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • XTX Topco held 21,295 shares of Citius Pharmaceuticals worth $19.2K as of Q1 2026.
  • XTX Topco sold 85,823 Citius Pharmaceuticals shares in Q1 2026, an estimated $69.3K.
  • Citius Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3558 holding.
  • XTX Topco first reported a position in Citius Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • XTX Topco's Citius Pharmaceuticals position peaked at $83.2K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.